Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNexus Gene Lab (BGLC) FCF Payout Ratio (2023 - 2024)

BioNexus Gene Lab's FCF Payout Ratio history spans 2 years, with the latest figure at 0.0 for Q3 2024.

  • For Q3 2024, FCF Payout Ratio rose 46.06% year-over-year to 0.0; the TTM value through Sep 2024 reached 0.0, changed N/A, while the annual FY2023 figure was 0.0, 131.88% down from the prior year.
  • FCF Payout Ratio for Q3 2024 was 0.0 at BioNexus Gene Lab, up from 0.0 in the prior quarter.
  • Across five years, FCF Payout Ratio topped out at 0.0 in Q3 2024 and bottomed at 0.06 in Q2 2023.